NCT06336902View on ClinicalTrials.gov

Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients with KRAS-Mutant Metastatic Colorectal Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

January 15, 2027

Study Completion Date

January 15, 2028

Conditions
Metastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC V8
Interventions
BIOLOGICAL

Balstilimab

Given IV

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

BIOLOGICAL

Botensilimab

Given IV

PROCEDURE

Computed Tomography

Undergo CT scan

OTHER

Dietary Intervention

Undergo FMD

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

DIETARY_SUPPLEMENT

Vitamin C

Given IV

Trial Locations (2)

90033

RECRUITING

Los Angeles General Medical Center, Los Angeles

RECRUITING

USC / Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER